All Type of News
British bio-pharmaceutical company Shire has begun the countdown of entry into Korea, so there is much attention towards the future of the Shire
British bio-pharmaceutical company Shire has begun the countdown of entry into Korea, so there is much attention towards the future of the Shire.
The biggest change due to Shire's entry is expected to be in the ADHD ...
National Health Insurance Corporation completed reimbursement contract of 2015 with average increase rate of 2.22%
National Health Insurance Corporation announced that they completed reimbursement contract of 2015 with 5 health care organizations including Korean Hospital Association, Korean Medical Association, and Korean Pharmac...
Sales of famous nutritional supplements seem to decrease
On June 5, according to the sales analysis of frequent OTC products in the first quarter from major listed pharmaceutical companies, sales of famous nutritional supplements seem to decrease.
The sales of national rep...
Canesten was temporarily out of stock faster than in previous years because of heat and humidity
On June 3, according to the Bayer, OTC drug Canesten cream 100g(70 won/1g) which is covered by insurance and OTC drug Canesten powder 30g which is not covered by insurance have been temporarily out of stock.
Bayer an...
The drug price of 'Jakabi' which is used in the treatment of myelofibrosis will be lowered about 40%
The drug price of 'Jakabi (ingredient ruxolitinib)' which is used in the treatment of a rare disease, myelofibrosis, will be lowered about 40%.
According to industry sources, on May 30, Novartis Korea submitted econo...
Pharma Science Korea is entering into domestic market in earnest
Pharma Science Korea which is a joint company of Kolmar Korea and Canadian generic specialized company Science, is entering into domestic market in earnest.
On June 3, according to the related industry, Pharma Scienc...
Celltrion announced that they will embark on the approval procedure of biosimilar 'Remsima' in the United States
On June 2, Celltrion announced that they will embark on the approval procedure of biosimilar 'Remsima' in the United States.
According to Celltrion, they plan to submit permission application for sales in the U.S. ba...
It was analyzed that trade deficit range of medicine is gradually getting bigger after the Korea-US FTA
It was analyzed that trade deficit range of medicine is gradually getting bigger after the Korea-US FTA.
On June 2, Health Industry Development Institute published brief 'Import and export trade effect on Health Indu...
Recently, there are increasingly large numbers of examples that small bio-pharmaceutical company buy bigger pharmaceutical company
Recently, there are increasingly large numbers of examples that small bio-pharmaceutical company buy bigger pharmaceutical company. The M & A with the form of 'David and Goliath' is analyzed to prove increased status ...
Kwangdong Pharmaceutical announced that they will not participate in the bidding of Dream Pharma
On June 2, Kwangdong Pharmaceutical announced that they will not participate in the bidding of Dream Pharma, followed by JW JoongWae.
Therefore, the list of companies which participate in the bidding of Dream Pharma ...
